The rally comes in spite of recent volatility, with the stock falling 3% over the past five sessions. While shares have posted a modest 10% gain over the past month, IREDA remains under pressure in ...

IREDA share price jumped over 3% ahead of the Q4 results today. The board of directors of IREDA will meet today to approve the financial results for the fourth quarter ended March 2025 as well as the ...

Watch as IREDA reveals Q4 earnings today! Key financials include a 27% jump in loan sanctions and 20% rise in disbursements. Stay updated!

IREDA now has 26.48 lakh retail shareholders, who now have a 20.25% stake in the company, in comparison to the 25.88 lakh small shareholders who had a 19.95% stake at the end of the December quarter.

Dr Reddy's has denied the workforce reduction claims. "We categorically deny the claim of a 25% workforce cost reduction and ...

Market analysts predict that IREDA will have great Q4 results in 2025, mostly as a result of the companys impressive operational metrics from Q3 FY25. IREDA has the authority to announce a 20% YoY ...

On market estimates regarding IREDA Q4 results in 2025, Atul Parakh, CEO of Bigul, said, "Based on the strong operational metrics from Q3 FY25, IREDA is expected to deliver robust financial results.

Indian benchmark indices Nifty 50 and Sensex ended the previous trade session higher. Nifty 50 closed at 22,828.55, while ...

ICICI Prudential Life, ICICI Lombard, and IREDA are among the major firms announcing their Q4 FY25 earnings on Tuesday. Analysts expect moderate growth, subdued margins, and strategic updates as key ...

T he fourth quarter earnings season continues in full swing with nine listed companies scheduled to report their financial results on Tuesday, April 15, 2025. Among the key names ...

Financial results of several broader companies will be analysed for their exposure to US, and impact of swings in raw material prices, at a time when an ongoing tariff war is engulfing business ...

Investors are closely monitoring these earnings reports to assess the financial health and future prospects of these companies.